CVS Trading Volume Surges 36.53% to $485 Million, Ranks 205th in Daily Volume

On June 11, 2025, CVS's trading volume reached $485 million, marking a 36.53% increase from the previous day. This surge placed CVS at the 205th position in the day's trading volume rankings. CVS's stock price rose by 2.27%, extending its winning streak to four consecutive days, with a total increase of 4.19% over the past four days.

CVS, along with Express Scripts and a lobby group, has filed a lawsuit against Arkansas over a new pharmacy law aimed at breaking up monopolies. The law, Act 624, prohibits pharmacy benefit managers (PBMs) from owning or operating pharmacies within the state. CVS and Express Scripts argue that the law is unconstitutional and preempted by federal regulations, claiming it will disrupt their operations and limit access to prescription drugs for Arkansans.

CVS and Cigna have also sued Arkansas over the PBM ban, asserting that PBMs have contributed to rising drug prices and local pharmacy closures. CVS has threatened to close more pharmacies if the law is enforced, which could lead to job losses and increased drug costs. The Pharmaceutical Care Management Association (PCMA) has filed a lawsuit seeking to block Act 624, arguing that it interferes with benefit plan design and Medicare Advantage plans.

CVS and Express Scripts have filed lawsuits in the U.S. District Court for the Eastern District of Arkansas, claiming that the law would force them to reorganize their national operations and disrupt mail-order prescription services. They argue that the law discriminates against out-of-state pharmacies and violates the Constitution's Dormant Commerce Clause and Equal Protection rights. CVS further alleges that the law is preempted by federal laws such as ERISA and the Medicare Prescription Drug Improvement and Modernization Act of 2003.

Express Scripts' complaint adds additional grounds, including violations of the Constitution's Privileges and Immunities Clause and the Bill of Attainder Clause. They contend that the law targets the nation's three largest PBMs and interferes with the federal government's TRICARE program. Arkansas Attorney General Tim Griffin has pledged to defend the Act vigorously, and the outcome of these lawsuits could have significant implications for PBM regulation across the country.